|
Parent Company Only Financial Information (Interim Condensed Statements of Cash Flows) (Details) (USD $)
In Thousands, unless otherwise specified
|
12 Months Ended |
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2011
|
| Operating Activities |
|
|
|
| Net income |
$ 12,510 |
$ 12,206 |
$ 10,210 |
| Adjustments to reconcile net income to cash provided by operations |
|
|
|
| Share-based payment awards |
554 |
643 |
615 |
| Depreciation |
2,556 |
2,417 |
2,521 |
| Deferred income tax expense (benefit) |
(1,208) |
616 |
389 |
| Changes in operating assets and liabilities which used cash |
|
|
|
| Other assets |
(122) |
(2,610) |
147 |
| Accrued interest and other liabilities |
1,954 |
(1,360) |
449 |
| Net cash provided by (used in) operating activities |
22,741 |
19,464 |
18,860 |
| Investing activities |
|
|
|
| Purchases |
(131,505) |
(207,035) |
(165,017) |
| Purchases of equipment and premises |
(2,488) |
(3,578) |
(2,520) |
| Net cash provided by (used in) investing activities |
(64,931) |
(101,874) |
(105,203) |
| Financing activities |
|
|
|
| Net increase (decrease) in other borrowed funds |
38,325 |
24,898 |
21,400 |
| Cash dividends paid on common stock |
(6,456) |
(6,074) |
(5,770) |
| Proceeds from the issuance of common stock |
3,618 |
2,898 |
2,302 |
| Common stock repurchased |
(2,375) |
(1,980) |
(1,507) |
| Common stock purchased for deferred compensation obligations |
(383) |
(505) |
(426) |
| Net cash provided by (used in) financing activities |
58,828 |
78,740 |
96,824 |
| Increase (decrease) in cash and cash equivalents |
16,638 |
(3,670) |
10,481 |
| Cash and cash equivalents at beginning of year |
24,920 |
28,590 |
18,109 |
| Cash and cash equivalents at end of year |
41,558 |
24,920 |
28,590 |
|
Parent Company [Member]
|
|
|
|
| Operating Activities |
|
|
|
| Net income |
12,510 |
12,206 |
10,210 |
| Adjustments to reconcile net income to cash provided by operations |
|
|
|
| Undistributed earnings of subsidiaries |
(7,003) |
(7,287) |
(5,527) |
| Undistributed earnings of equity securities without readily determinable fair values |
74 |
(459) |
160 |
| Share-based payment awards |
554 |
643 |
615 |
| Depreciation |
174 |
114 |
123 |
| Net amortization of AFS securities |
2 |
4 |
7 |
| Deferred income tax expense (benefit) |
(305) |
425 |
(48) |
| Changes in operating assets and liabilities which used cash |
|
|
|
| Other assets |
(51) |
(513) |
7 |
| Accrued interest and other liabilities |
1,238 |
(98) |
757 |
| Net cash provided by (used in) operating activities |
7,193 |
5,035 |
6,304 |
| Investing activities |
|
|
|
| Maturities, calls, and sales of AFS securities |
395 |
370 |
585 |
| Purchases |
0 |
0 |
(3,000) |
| Purchases of equipment and premises |
(146) |
(239) |
(87) |
| Repayment of advances to subsidiaries |
(299) |
(50) |
0 |
| Net cash provided by (used in) investing activities |
(50) |
81 |
(2,502) |
| Financing activities |
|
|
|
| Net increase (decrease) in other borrowed funds |
(1,350) |
(597) |
2,772 |
| Cash dividends paid on common stock |
(6,456) |
(6,074) |
(5,770) |
| Proceeds from the issuance of common stock |
3,618 |
2,898 |
2,302 |
| Common stock repurchased |
(2,375) |
(1,980) |
(1,507) |
| Common stock purchased for deferred compensation obligations |
(383) |
(505) |
(426) |
| Net cash provided by (used in) financing activities |
(6,946) |
(6,258) |
(2,629) |
| Increase (decrease) in cash and cash equivalents |
197 |
(1,142) |
1,173 |
| Cash and cash equivalents at beginning of year |
332 |
1,474 |
301 |
| Cash and cash equivalents at end of year |
$ 529 |
$ 332 |
$ 1,474 |